Karachi: Sardar Chemical Industries Limited has disclosed a recent transaction involving the acquisition of shares by a key executive, as per the regulations of the Pakistan Stock Exchange (PSX). The disclosure, made under PSX Regulation 5.6.4, provides details of the transaction executed by an executive member of the company.

The transaction was carried out by Muhammad Amir Iqbal, an Executive Director of Sardar Chemical Industries Limited. According to the information available, the acquisition was made in the form of Central Depository Company (CDC) share certificates. The market transaction was executed through the CDC on May 6, 2025.

The nature of the transaction was a purchase, with Muhammad Amir Iqbal acquiring 500 shares of the company at a rate of 33.00 per share. This transaction brings his cumulative shareholding to 500 shares, representing a cumulative percentage of 0.01 in Sardar Chemical Industries Limited.

According to information available from the Pakistan Stock Exchange (PSX), such disclosures are mandatory for directors, executives, and substantial shareholders, along with their spouses and minors, to ensure transparency and compliance with regulatory requirements.

The designated market category for the transaction is not explicitly mentioned in the disclosure. However, the information highlights the ongoing activities and shareholding changes within Sardar Chemical Industries Limited, as monitored by the PSX.